AAAAAA

   
Results: 1-8 |
Results: 8
SECONDARY DRUG-RESISTANCE IN BREAST-CANCER - FAILURE TO REVERSE WITH ORAL NIFEDIPINE
Authors: HOLMES FA LOPEZ A MAVLIGIT G FRASCHINI G FRYE D HORTOBAGYI GN
Citation: Fa. Holmes et al., SECONDARY DRUG-RESISTANCE IN BREAST-CANCER - FAILURE TO REVERSE WITH ORAL NIFEDIPINE, International journal of cancer, 73(2), 1997, pp. 184-186
CHEMOTHERAPY-INDUCED NEUTROPENIA AND FEVER IN PATIENTS WITH METASTATIC BREAST-CARCINOMA RECEIVING SALVAGE CHEMOTHERAPY
Authors: RAHMAN Z ESPARZAGUERRA L YAP HY FRASCHINI G BODEY G HORTOBAGYI G
Citation: Z. Rahman et al., CHEMOTHERAPY-INDUCED NEUTROPENIA AND FEVER IN PATIENTS WITH METASTATIC BREAST-CARCINOMA RECEIVING SALVAGE CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1150-1157
SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HOLMES FA MADDEN T NEWMAN RA VALERO V THERIAULT RL FRASCHINI G WALTERS RS BOOSER DJ BUZDAR AU WILLEY J HORTOBAGYI GN
Citation: Fa. Holmes et al., SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2713-2721
PHASE I-II STURDY - TRICIRIBINE (TRICYCLIC NUCLEOSIDE PHOSPHATE) FOR METASTATIC BREAST-CANCER
Authors: HOFFMAN K HOLMES FA FRASCHINI G ESPARZA L FRYE D RABER MN NEWMAN RA HORTOBAGYI GN
Citation: K. Hoffman et al., PHASE I-II STURDY - TRICIRIBINE (TRICYCLIC NUCLEOSIDE PHOSPHATE) FOR METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 254-258
PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER
Authors: DHINGRA K FRYE D NEWMAN RA WALTERS R THERIAULT R FRASCHINI G SMITH T BUZDAR A HORTOBAGYI GN
Citation: K. Dhingra et al., PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER, Clinical cancer research, 1(7), 1995, pp. 691-697
PHASE-II TRIAL OF DOCETAXEL - A NEW, HIGHLY EFFECTIVE ANTINEOPLASTIC AGENT IN THE MANAGEMENT OF PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER
Authors: VALERO V HOLMES FA WALTERS RS THERIAULT RL ESPARZA L FRASCHINI G FONSECA GA BELLET RE BUZDAR AU HORTOBAGYI GN
Citation: V. Valero et al., PHASE-II TRIAL OF DOCETAXEL - A NEW, HIGHLY EFFECTIVE ANTINEOPLASTIC AGENT IN THE MANAGEMENT OF PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2886-2894
PREVALENCE OF ANTI-HCV ANTIBODIES IN HEALTHY-SUBJECTS WITHOUT RISK-FACTORS FOR BLOOD-BORNE VIRAL-INFECTIONS
Authors: BARBARINI G FERRARI G FRASCHINI G GUIDA A BISSOLATI M GATTI M CHIESA A GARAVELLI G
Citation: G. Barbarini et al., PREVALENCE OF ANTI-HCV ANTIBODIES IN HEALTHY-SUBJECTS WITHOUT RISK-FACTORS FOR BLOOD-BORNE VIRAL-INFECTIONS, Hepatology, 22(4), 1995, pp. 1142-1142
PHASE-II STUDY OF DEOXYSPERGUALIN IN METASTATIC BREAST-CANCER
Authors: DHINGRA K VALERO V GUTIERREZ L THERIAULT R BOOSER D HOLMES F BUZDAR A FRASCHINI G HORTOBAGYI G
Citation: K. Dhingra et al., PHASE-II STUDY OF DEOXYSPERGUALIN IN METASTATIC BREAST-CANCER, Investigational new drugs, 12(3), 1994, pp. 235-241
Risultati: 1-8 |